日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel serum small extracellular vesicle miRNAs with multi-target RCA-CRISPR sensor for liver cancer detection.

利用多靶点 RCA-CRISPR 传感器检测新型血清小细胞外囊泡 miRNA 以进行肝癌检测。

Fan Tingting, Zhou Bo, Chen Hui, Liu Li-Ping, Ni Yong, Zhang Wei, Ye Lizhen, Chen Yifei, Zhang Dandan, Yang Shiqi, Bai Yu, Liu Funian, Zhi Cailian, Xu Guanghong, Zheng Bo, Lu Songlin, Qiu Cheng, Ding Zijian, Chen Yan, Jiang Yuyang

Targeting HDAC and PARP Enhances STING-Dependent Antitumor Immunity in STING-Deficient Tumor

靶向 HDAC 和 PARP 可增强 STING 缺陷型肿瘤中 STING 依赖性抗肿瘤免疫

Mao, Chengzhou; Fan, Weiwen; Liu, Jiaqi; Yang, Fangzhou; Li, Wenkai; Li, Lulu; Shi, Zhichao; Li, Qinyuan; Yuan, Zigao; Jiang, Yuyang; Chu, Bizhu

Overexpression of lncRNA EPB41L4A-AS1 Induces Metabolic Reprogramming in Trophoblast Cells and Placenta Tissue of Miscarriage

lncRNA EPB41L4A-AS1 的过表达诱导流产滋养层细胞和胎盘组织代谢重编程

Zhu, Yuanchang; Liu, Qing; Liao, Meijian; Diao, Lianghui; Wu, Tonghua; Liao, Weijie; Wang, Ziqiang; Li, Bing; Zhang, Shikuan; Wang, Songmao; Xie, Weidong; Jiang, Yuyang; Xu, Naihan; Zeng, Yong; Yang, Burton B; Zhang, Yaou

Enhancing plasmacytoid dendritic cell functionality with all-trans retinoic acid for improved multiple myeloma therapy

利用全反式维甲酸增强浆细胞样树突状细胞功能以改善多发性骨髓瘤治疗

Wanli Yu ,Wenting Tang ,Wei Lin ,Ling Jiang ,Yuyang Xiang ,Yinyin Li ,Yang Zhou ,Yuyang Chen ,Wenli Zhao ,Yihan Zhu ,Xiaolei Wei ,Yu Hu ,Enguang Bi

Serum metabolomics to identify molecular subtypes and predict XELOX efficacy in colorectal cancer

血清代谢组学用于识别分子亚型并预测XELOX疗法在结直肠癌中的疗效

Zhang, Yijie; Ye, Lizhen; Qin, Ying; Qiu, Cheng; Sun, Qinsheng; Fan, Tingting; Chen, Yan; Jiang, Yuyang

Dynamics of street environmental features and emotional responses in urban areas: implications for public health and sustainable development

城市街道环境特征与情绪反应的动态变化:对公共卫生和可持续发展的影响

Huang, Yangfei; Zhong, Chenjian; He, Tangtao; Jiang, Yuyang

An interpretable artificial intelligence framework for designing synthetic lethality-based anti-cancer combination therapies.

一种用于设计基于合成致死性的抗癌联合疗法的可解释人工智能框架

Wang Jing, Wen Yuqi, Zhang Yixin, Wang Zhongming, Jiang Yuyang, Dai Chong, Wu Lianlian, Leng Dongjin, He Song, Bo Xiaochen

Corrigendum for "LncRNA EPB41L4A-AS1 regulates glycolysis and glutaminolysis by mediating nucleolar translocation of HDAC2" [eBioMedicine 41 (2019) 200-213]

对“LncRNA EPB41L4A-AS1 通过介导 HDAC2 的核仁易位来调节糖酵解和谷氨酰胺分解”的更正 [eBioMedicine 41 (2019) 200-213]

Liao, Meijian; Liao, Weijie; Xu, Naihan; Li, Bing; Liu, Fuhai; Zhang, Shikuan; Wang, Yanzhi; Wang, Songmao; Zhu, Yuanchang; Chen, Deheng; Xie, Weidong; Jiang, Yuyang; Cao, Liu; Yang, Burton B; Zhang, Yaou

Novel dual inhibitors of PARP and HDAC induce intratumoral STING-mediated antitumor immunity in triple-negative breast cancer

新型PARP和HDAC双重抑制剂可诱导三阴性乳腺癌肿瘤内STING介导的抗肿瘤免疫

Zhu, Qingyun; Dai, Qiuzi; Zhao, Lei; Zheng, Chang; Li, Qinyuan; Yuan, Zigao; Li, Lulu; Xie, Zhuoye; Qiu, Zixuan; Huang, Wenjun; Liu, Guowen; Zu, Xuyu; Chu, Bizhu; Jiang, Yuyang

Design and Synthesis of c-Met and HDAC Dual Inhibitors for the Treatment of Breast Cancer

c-Met和HDAC双重抑制剂的设计与合成及其在乳腺癌治疗中的应用

Wang, Zuoyang; Shi, Zhichao; Yang, Shiqi; Niu, Zizhou; Shu, Kaifei; Chen, Linbo; Zhi, Cailian; Liu, Funian; Huang, Wenjun; Fan, Tingting; Jiang, Yuyang